Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs Acquiring UK Lyophilized Reagent Maker Fluorogenics

NEW YORK – Life science reagents supplier New England Biolabs said on Monday that it has agreed to acquire UK-based lyophilization R&D service company Fluorogenics.

Under the terms of the agreement, Fluorogenics will become a wholly-owned subsidiary of NEB and be part of its OEM and Customized Solutions business. Financial terms of the deal were not disclosed.

NEB currently supplies research-use-only reagents that its customers can use for further development and validation in diagnostic assays. The company said it is looking to increase its ability to offer lyophilized reagents that can withstand ambient shipping and storage.

"The acquisition of [Fluorogenics] enables NEB to combine our expertise in enzyme manufacturing and assay development with their expertise in lyophilization, providing a complete solution for our customers," NEB CEO Jim Ellard said in a statement. "It also further solidifies our ability to service customers in the molecular diagnostics space."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.